Balaxi Pharmaceuticals Limited Financial Overview
Balaxi Pharmaceuticals Limited's market cap is currently ₹307.28M. The company's EPS TTM is ₹; its P/E ratio is 7.67; Balaxi Pharmaceuticals Limited is scheduled to report earnings on November 11, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.